Skip to main content
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1978 Oct;14(4):549–552. doi: 10.1128/aac.14.4.549

Comparison of the In Vitro Activity of Bay k 4999 and Piperacillin, Two New Antipseudomonal Broad-Spectrum Penicillins, with Other β-Lactam Drugs

R Wise 1, J M Andrews 1, K A Bedford 1
PMCID: PMC352506  PMID: 102245

Abstract

Bay k 4999 and piperacillin, two new substituted ampicillins, were compared with other β-lactam antibiotics, including carbenicillin, azlocillin, mezlocillin, benzylpenicillin, ampicillin, and cefoxitin, against a wide range of gram-positive and -negative organisms. Bay k 4999 and piperacillin were extremely active against Pseudomonas aeruginosa (50% inhibited by 2 μg/ml), being about 16-fold more active than carbenicillin. Bay k 4999 was the most active drug against Escherichia coli (50% inhibited by 0.5 μg/ml) and Klebsiella spp. (50% inhibited by 2 μg/ml). Piperacillin and Bay k 4999 were equally active against Proteus spp., and piperacillin had high activity against Bacteroides fragilis (50% inhibited by between 1 and 2 μg/ml).

Full text

PDF
549

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bodey G. P., Pan T. Mezlocillin: in vitro studies of a new broad-spectrum penicillin. Antimicrob Agents Chemother. 1977 Jan;11(1):74–79. doi: 10.1128/aac.11.1.74. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Fiedelman W., Webb C. D. Clinical evaluation of carbenicillin in the treatment of infection due to anaerobic bacteria. Curr Ther Res Clin Exp. 1975 Sep;18(3):441–451. [PubMed] [Google Scholar]
  3. O'Callaghan C. H., Morris A., Kirby S. M., Shingler A. H. Novel method for detection of beta-lactamases by using a chromogenic cephalosporin substrate. Antimicrob Agents Chemother. 1972 Apr;1(4):283–288. doi: 10.1128/aac.1.4.283. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Sanders C. C., Sanders W. E., Jr BL-P1654: a bacteriostatic penicillin? Antimicrob Agents Chemother. 1975 Apr;7(4):435–440. doi: 10.1128/aac.7.4.435. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Stewart D., Bodey G. P. Azlocillin: in vitro studies of a new semisynthetic penicillin. Antimicrob Agents Chemother. 1977 May;11(5):865–870. doi: 10.1128/aac.11.5.865. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Ueo K., Fukuoka Y., Hayashi T., Yasuda T., Taki H., Tai M., Watanabe Y., Saikawa I., Mitsuhashi S. In vitro and in vivo antibacterial activity of T-1220, a new semisynthetic penicillin. Antimicrob Agents Chemother. 1977 Oct;12(4):455–460. doi: 10.1128/aac.12.4.455. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Wise R., Gillett A. P., Andrews J. M., Bedford K. A. Activity of azlocillin and mezlocillin against gram-negative organisms: comparison with other penicillins. Antimicrob Agents Chemother. 1978 Apr;13(4):559–565. doi: 10.1128/aac.13.4.559. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Wise R., Reeves D. S. Clinical and laboratory investigations on ticarcillin, an anti-pseudomonal antibiotic. Chemotherapy. 1974;20(1):45–51. doi: 10.1159/000221790. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES